Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Latanoprostene bunod vs Latanoprost in Normal Tension Glaucoma
KCT0011618Phase 4
Key facts
- Status
- Active, not recruiting
- Start
- Mar 2023
- Countries
- 1
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Conditions
- normal tension glaucoma (NTG)
01
Overview
Phase 4, randomised, single-blind trial in normal tension glaucoma (NTG) comparing Latanoprostene bunod arm with Latanoprost arm (2 arms). Started Mar 2023; status: active, not recruiting.
02
Design
2 arms- Study design
- RandomizedSingle-blind
Latanoprostene bunod arm
Patients receive latanoprostene bunod monotherapy for normal tension glaucoma.
Latanoprost arm
Patients receive latanoprost monotherapy for normal tension glaucoma.
03
Who it enrols
Adult patients in Korea with a diagnosis of normal tension glaucoma; healthy volunteers are not included.
Beyond the preview
Go deeper on KCT0011618.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011618.